Dr. Tobias Reinl

Dr. Tobias Reinl is currently the Director QA Analytics R&D at Alvotech and the Head of Quality Unit at GlycoThera. Dr. Tobias has expertise in quality assurance and management according to international GMP standards, quality control for biopharmaceuticals, and deviation, OOS, risk management, CAPA, equipment qualification, method validation, self-inspection, SOP creation and training, optimization of QM processes, and communication. In the past, Dr. Tobias has also served as QA Manager and Head of R&D Cell and Molecular Biology, focusing on Glyco-Engineering, Golgi-Modification, and Targeted Integration of Glycosyltransferases. During their postdoc position at Helmholtz Center for Infection Research, Dr. Tobias gained valuable scientific experience.